Standard BioTools (LAB)

• Market cap: $390M
• 1 day: 0.00%
• 5 days: -1.87%
• 1 month: -7.89%
• 3 months: -4.55%
• 6 months: -45.03%
• Year to date: -40.00%
• 1 year: -53.54%
• 5 years: -73.62%
• 10 years: -95.72%
• Sector: Healthcare
• Industry: Medical Devices

About: Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Employees: 818

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

50% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 16

4% more funds holding

Funds holding: 142 [Q4 2024] → 147 (+5) [Q1 2025]

0.47% less ownership

Funds ownership: 74.78% [Q4 2024] → 74.3% (-0.47%) [Q1 2025]

7% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 42

33% less funds holding in top 10

Funds holding in top 10: 3 [Q4 2024] → 2 (-1) [Q1 2025]

38% less capital invested

Capital invested by funds: $487M [Q4 2024] → $304M (-$183M) [Q1 2025]

90% less call options, than puts

Call options by funds: $6K | Put options by funds: $62K